HCA HEALTHCARE INC

Health‑care employment trends show HCA Healthcare thriving: steady hiring, modest wage hikes, and operational resilience amid a muted economy.

HCA Healthcare reports Q2 2026 revenue of $20.2 bn, a 7% YoY rise, while EPS hits $3.20, showcasing steady growth and a robust balance sheet amid healthcare sector momentum.

HCA Healthcare’s latest earnings show modest EPS dip but steady revenue and strong cash flow, underscoring solid liquidity and tech investment for future growth.

HCA Healthcare partners with Parlance’s AI voice platform to streamline patient calls, cut agent work, boost satisfaction, and deliver quick ROI across its hospitals.

Explore how HCA Healthcare’s massive photodisinfection trial could slash surgical site infections, cut costs, and reshape the infection‑control market.

Explore how HCA Healthcare’s nasal photodisinfection trial shows 25% SSI reduction, 85% S. aureus clearance, and AI‑powered clinical tools are reshaping surgery outcomes and efficiency.

Discover how HCA Healthcare’s decade‑long stock outperformed the market—uncover the drivers, risks, and future prospects for long‑term investors.

TD Cowen cuts HCA Healthcare’s target price, citing tighter margins, slower revenue growth, and a competitive, regulated market—yet remains bullish on its long‑term prospects.

Discover why HCA Healthcare’s modest weight in Antipodes Global Value Active ETF signals strong value, resilience and growth potential for diversified investors.

HCA Healthcare’s DCF shows a 12‑15% upside, driven by its diverse hospital portfolio, outpatient expansion, and telehealth investments—yet market sentiment and macro‑economic shifts could affect short‑term gains.